Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07014-xSource: DataRank Database

Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study is a research paper published in Breast Cancer Research and Treatment (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.21)OA: hybridTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Sarah Van Alsten,Padmashree C.G. Rida,Victoria L. Seewaldt ORCID,Melissa A. Troester ORCID,Nikita Jinna ORCID

Live enrichment

PubMed:37438515 PMC:PMC10361868 OpenAlex:https://openalex.org/W4384028527

National Institutes of Health

Grant: P01CA151135

National Institutes of Health

Grant: NIH/NCI P50-CA058223

NCI NIH HHS

Grant: P50 CA058223

NCI NIH HHS

Grant: T32 CA057726

NCI NIH HHS

Grant: P30 CA016086

NIEHS NIH HHS

Grant: P30 ES010126

City of Hope

FWCI

0.21

Citation Percentile

0.5%

Citation Trend

2023

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s10549-023-07014-x.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-023-07014-x.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-023-07014-x/fulltext.html

journalhttps://doi.org/10.1007/s10549-023-07014-x

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37438515

Fields of Study

Breast Cancer Treatment StudiesBRCA gene mutations in cancerEstrogen and related hormone effectsHumansFemaleBreast NeoplasmsAndrogensReceptors, EstrogenTriple Negative Breast NeoplasmsReceptors, AndrogenPrognosisRNAErb-b2 Receptor Tyrosine Kinases

MeSH Terms

AndrogensBreast NeoplasmsFemaleHumansPrognosisReceptors, AndrogenReceptors, EstrogenRNAErb-b2 Receptor Tyrosine KinasesReceptor, ErbB-2Triple Negative Breast Neoplasms

Keywords

Androgen receptorBreast cancerEstrogen receptorInternal medicineOncologyMedicineCancerBiologyProstate cancerDNA repairTriple-negative Breast CancerMultigene SignatureCarolina Breast Cancer Study

Sustainable Development Goals

SDG 0: Good health and well-being

Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study

FAIR Checklist

Authors (5)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)